evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract
18975,GENE_BACKGROUND,,"TRAF2 encodes for TNF receptor associated factor 2 that interacts with and transduces signals from the Tumor necrosis factor (TNF) receptor to activate the NF-kappa B pathway and Jun amino-terminal kinases (JNK) (PMID:8565075, 8985011, 8898208). It also mediates signaling from CD40 in immune cells (PMID:7544915, 15539150). Through its RING domain it has ubiquitin ligase activity (PMID: 23142077, 20577214). TRAF2 regulates lymphocyte proliferation and survival and the immune response (PMID:9390693, 9390694, 11435475). It also has a role in hematopoietic stem cells by mediating activation of the MAPK pathway (PMID:25824820). In tumor cells TRAF2 is involved in NF-kappa B activation leading to tumor cell survival and resistance to targeted therapy (PMID: 25843712,19336568, 22589389). Mutations have been found in multiple myeloma, lymphomas, and nasopharyngeal carcinomas (PMID:17692805, 24362935,19412164, 23868181). It has also been found to be amplified in epithelial cancers (PMID: 24362534).",,2017-01-18,,7186,TRAF2,TNF receptor associated factor 2,False,ENST00000247668,NM_021138.3,TRAP3,MGC:45012,TRAP,False,9390693,TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.,Immunity,0001-11-01,7,5,703-13,Lee SY et al,,,0001-11-01,,25843712,NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.,Cell reports,2018-04-07T20:15:00,11,True,98-110,Blakely CM et al,doi: 10.1016/j.celrep.2015.03.012,,2018-04-07T01:10:00,,9390694,"Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.",Immunity,0001-11-01,7,5,715-25,Yeh WC et al,,,0001-11-01,,15539150,TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.,Immunity,2018-11-01T20:04:00,21,5,629-42,Grech AP et al,,,0001-11-01,,19336568,Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation.,Cancer research,2018-04-15T20:09:00,69,8,3665-72,Thomas GS et al,doi: 10.1158/0008-5472.CAN-08-4867,,0001-04-15,,24362935,Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma.,Nature medicine,2018-01-01T20:14:00,20,True,87-92,Rahal R et al,doi: 10.1038/nm.3435,,0001-01-01,,19412164,Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.,Nature,2018-06-04T20:09:00,459,7247,717-21,Compagno M et al,doi: 10.1038/nature07968,,0001-06-04,,8565075,TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.,Cell,0001-01-26,84,2,299-308,Hsu H et al,,,2018-01-26T03:08:00,,8898208,Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.,Cell,0001-11-01,87,3,565-76,Liu ZG et al,,,0001-11-01,,25824820,Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.,The Journal of experimental medicine,2018-04-06T20:15:00,212,4,525-38,Tesio M et al,doi: 10.1084/jem.20141438,,0001-04-06,,17692805,Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.,Cancer cell,2018-08-01T20:07:00,12,2,131-44,Keats JJ et al,,,0001-08-01,,23142077,TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer.,Molecular cell,2017-12-28T20:12:00,48,6,888-99,Gonzalvez F et al,doi: 10.1016/j.molcel.2012.09.031,,0001-12-28,,23868181,Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.,The Journal of pathology,2018-11-01T20:13:00,231,3,311-22,Chung GT et al,doi: 10.1002/path.4239,,0001-11-01,,11435475,Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45).,The Journal of experimental medicine,2018-07-02T20:01:00,194,True,89-98,Lieberson R et al,,,0001-07-02,,22589389,MicroSCALE screening reveals genetic modifiers of therapeutic response in melanoma.,Science signaling,2018-05-15T20:12:00,5,224,rs4,Wood KC et al,doi: 10.1126/scisignal.2002612,,2018-05-15T02:24:00,,20577214,Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.,Nature,2018-06-24T20:10:00,465,7301,1084-8,Alvarez SE et al,doi: 10.1038/nature09128,,0001-06-24,,8985011,Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway.,"Science (New York, N.Y.)",0001-01-10,275,5297,200-3,Natoli G et al,,,0001-01-10,,7544915,TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.,"Science (New York, N.Y.)",0001-09-08,269,5229,1424-7,Rothe M et al,,,0001-09-08,,24362534,TRAF2 is an NF-κB-activating oncogene in epithelial cancers.,Oncogene,2018-01-08T20:15:00,34,2,209-16,Shen RR et al,doi: 10.1038/onc.2013.543,,0001-01-08,
18974,GENE_SUMMARY,,"TRAF2 is a protein that mediates signaling from members of the TNF receptor family and regulates downstream NFkB pathway activation. Mutations are found in meyloma, lymphomas, and more rarely in epithelial cancers.",,2017-01-18,,7186,TRAF2,TNF receptor associated factor 2,False,ENST00000247668,NM_021138.3,TRAP3,MGC:45012,TRAP,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
